follow note publish morn link recal ko
report better expect organ sale growth quarter in-lin ep
result gave initi guidanc msd organ sale growth
compar ep growth opinion ko continu outpac
large-cap cpg compani organ top-lin growth see fall
bottom line would expect compani valuat premium peer
remain expand reiter buy
recap morn ko report result includ net sale
yoy estim yoy
consensu estim yoy organ revenu grew
yoy back impact extra day quarter
expect adjust ep estim
in-lin consensu estim addit ko gave initi
outlook includ organ sale growth currenc
neutral oper incom growth report oper incom growth
impact fx compar ep growth equat
ep note ep outlook in-lin street
price/mix volum balanc opinion key discuss
call around compani expect make-up organ
sale growth go forward growth larg driven price/mix
compani focus innov initi drive posit mix saw
fx relat price benefit howev ko state long term
expect balanc contribut price/mix volum
overal organ growth believ improv trend develop market
continu volum growth emerg market volum contribut
adjust estim reiter buy rais ep
estim slightli respect
opinion strong top bottom line guidanc despit continu fx
headwind driver stock move today vs
ko continu outpac large-cap cpg compani organ top-
line growth see fall bottom line would expect
compani valuat premium peer remain expand
rais price target equat ep
estim premium peer reiter buy
tr target
dollar million except per-shar data
europ africa
corpor elimin
good sold
equiti affili
europ africa
corpor elimin
sourc compani report suntrust robinson humphrey estim
price
page
base atlanta georgia coca-cola compani world largest beverag compani ko
main product includ sparkl still beverag concentr market broad portfolio
icon brand includ diet zero sprite fanta minut maid vitaminwat
powerad own licens product countri world-wide
buy rate base ko lead posit grow non-alcohol ready-to-drink nartd
categori renew focu long-term profit refranchis owned-bottl network
us intern
valuat risk
price target base multipl ep estim premium large-cap
cpg peer group rang believ premium multipl justifi ko outperform
peer organ growth margin improv standpoint view well posit
post msd organ growth fulfil total beverag compani strategi around world see
improv trend us post bottler re-franchis risk rate price target includ
continu macroeconom malais regulatori uncertainti commod inflat exposur
currenc fluctuat competit
chappel herebi certifi view express research report accur reflect
person view subject compani secur also certifi
receiv direct indirect compens exchang express specif
recommend report
